Breath Diagnostics, Inc. (“Breath-Dx”), is a medical device diagnostics company developing a novel, patented breath analysis system to quantify cancer-specific markers in exhaled breath. The Company’s proprietary technology, OneBreath®, offers a unique solution providing accurate, affordable, and safe lung cancer detection by analysing a single exhaled breath. Breath Dx’s innovative platform can selectively detect a spectrum of predictive markers and therefore has the potential to expand into other cancer indications as well as a variety of other disease states.
OneBreath® utilizes a proprietary silica microreactor coated with a novel chemical reagent that captures specific Volatile Organic Compounds (VOCs) from a single exhaled breath sample which can be quantitatively analyzed by conventionally available liquid chromatography-mass spectrometers. The OneBreath® test can deliver definitive results within 24 hours of sample collection using the safest method for lung cancer detection/diagnosis to date.
The OneBreath® test can be done in office-based, and retail (pharmacy/drugstores) settings, enabling greater accessibility to lung cancer screening and diagnosis for the general population, which will enhance the potential for early detection.
President & Chief Executive Officer
Brian brings 35+ years of medical device and biotech experience to his role as the President & CEO at Breath Diagnostics. His pedigree reflects an upward progression within several large medical device companies including C.R. Bard, Stryker, Wright Medical, and Empi. He also served as the President & CEO of Etex Corporation. Brian has extensive international and domestic experience in diverse market segments including, bone-regeneration biomaterials, orthopaedic implants, pain management, capital equipment, endoscopy, and high-volume case good disposals.
Founder & Chairman
Dr. Bousamra is the Director of Thoracic Surgery at Baptist Health Floyd. He is a graduate of University of Michigan Medical School and a member of the American Association for Thoracic Surgery. He has authored over 50 peer-reviewed publications and holds several patents on methods to detect cancer.
Founder & Director
Dr. van Berkel, a graduate of MIT, serves as Surgical Director of Lung Transplant at Jewish Hospital, Louisville, KY. The majority of his clinical practice involves the treatment of lung cancer, and his recent research is focused on novel mechanisms for screening at-risk populations for lung cancer.
Founder
Dr. Nantz is the past Chair of the Department of Chemistry at University of Louisville. He has authored more than 130 peer-reviewed scientific publications and is Inventor on 17 issued US patents. He has authored two chemistry textbooks that have been internationally adopted at more than 200 universities. He also has co-founded 3 startup companies and currently serves on the Board of Directors for two of these companies.
Founder
Dr. Fu is an Associate Professor of Chemical Engineering at University of Louisville. His research program created the silicon microreactor technology used by Breath-Dx for analysis of trace volatile organic compounds in exhaled breath. Dr. Fu has authored more than 80 peer-reviewed publications and is Inventor on 6 patents.
Child Health Imprints (CHIL), a company incorporated for improving clinical care outcomes in neonatal intensive care units (NICU) using bed side IoT and Artificial intelligence based disease prediction capability.According to a WHO report published in 2017, globally 2.5 million babies die within the first 27 days of their life. Prematurity, infections, delay in treatment, skill manpower shortage and human-based medical errors are the major causes of neonatal deaths. Lack of data integration amongst multiple devices (patient monitor, ventilaor, blood gas machines, infusion pumps) in a NICU, EMR adoption in NICU and unified neonatal workflow practices are urgent needs of rising neonatal births across world.
Harpreet Singh & Ravneet Kaur faced similar challenges when their twins were born preterm and one of twins passed away within one week of birth due to NEC. They built bedside IoT based technology comprising of NEO that interoperates with various medical devices used in NICU. NEO aggregated data in a vendor agnostic manner offering temporal (longitudinal) data of their stay in NICU that reduces manual charting effort of nurses. The solution also comprises a bedside tablet based interface to ensure prospective data entry, which is supported by artificial intelligence based iNICU analytics engine that infers millions of data-points persisted in time-series representation. By leveraging clinical rules and deep learning based disease specific (Respiratory Distress, Sepsis, BPD) analytical models, iNICU assist the neonatologists in focussing on neonatal care and identifying the early onset of diseases. They further plan to setup collaboration with machine learning expert in one of the largest university NICU in US and improve their decision support offering as the company launches from its Singapore home base to grow in new markets in Asia.
Co-Founder, CEO
Accomplished engineer/seasoned entrepreneur with over 20 years of experience in Healthcare Informatics and Engineering domain with a record of achievements in scientific and technology leadership roles. International product and consulting experience across Europe, USA and Asia with Mckinsey, Philips, Stryker and Intuit. Experience spanning diverse industries (Healthcare , Enterprise Software & Services, Management Consulting, Research & Development) and skill sets (Product Management, Value Engineering, Business Head, Sales Strategy, Analytics, Systems Engineering and Strategy Consulting) Founded iNICU in 2016, a company streamlining the entire workflow of NICU by integrating data from various medical devices and other sources. Earlier, setup and led a multidisciplinary teams of 5 - 40 members building software products for US and German market. Involved in research and all aspects of software development and product management. Collaborated with University of Wisconsin, Madison on number of academic service contracts along with industry collaborations with EGI and Philips.
Co-Founder, VP
Seasoned entrepreneur with over 12 years of experience in healthcare domain , research & development , building and managing teams, project development , project management and unparalleled client service. Skilled relationship builder with clients in separately managed accounts. Experience in understanding various business process , gathering business requirements, identifying risks and doing impact analysis.Founded iNICU in 2016 with the purpose of saving neonatal lives though predictive analytics . Collaborated with mathematicians, research analysts, neonatologists, biomedical and IoT team for generating publications in reputed scientific journals. Driven strong sales, channel and marketing alignment with initiatives and processes for traction and scaling up in ASEAN and US . Software development and engineering skills with genuine enthusiasm for resolving business challenges through technical innovation. Directed projects in healthcare domain focusing on IOT , Big Data and Analytical techniques.
Homage is a complete care solution that combines trained care professionals with smart technology to manage and provide on-demand home and community-based caregiving to seniors and adults, allowing them to age and recover at home with grace, control and dignity.
Home-grown as a technology platform in Singapore, Homage has received awards including Social Enterprise of the year by Singapore President’s Challenge, RaiSE Leap For Good, Most Promising Startup by OCBC Emerging Enterprise as well as Best Home Care Operator by Aging Asia. Homage was also cited by Singapore’s Prime Minister Lee Hsien Loong as giving many seniors and their families peace of mind.
Co-Founder, CEO
Gillian Tee is the co-founder and CEO of Homage. Gillian’s mission with Homage is to equip and inspire a new generation of caregivers to provide individualized and personal care at scale. Enabling all to live, age and recover back within their communities and homes with more choice and fulfilment is what motivated Gillian to build Homage and is at the heartbeat of the entire Homage team.
Prior to Homage, Gillian co-founded Rocketrip, a Y-Combinator, Google Ventures and Bessemer Ventures-backed travel technology company based in New York City and Silicon Valley that rewards employee for generating cost savings. Prior to Rocketrip, Gillian held various sales, business development, product management and technology leadership positions at Amazon and Accenture. Gillian has an MBA and Master of International Affairs from Columbia Business School and Columbia School of International and Public Affairs; she also studied Computer Science with a focus on Machine Learning and Artificial Intelligence at the University of Melbourne.
Co-Founder, COO
Lily Phang is the co-founder and COO of Homage. With a passion to bring health into the community, she believes that home care should be easily accessible and yet affordable for all. Seeing seniors receiving quality care and care professionals finding meaning in their lives through caregiving keeps Lily energized everyday.
Lily started her career with International SOS, oversaw 24-hour emergency alarm centres in Singapore, Greater China, and the wider Asian region. She was involved in the setup of a joint-venture in Stuttgart, Germany, and also several company-wide mega projects, such as shared services project in Asia Region, IT implementation for all the alarm centres. She ran Specialist Outpatient Clinics and Call Centres with Jurong Health for more than two years before joining Singapore General Hospital Hospital’s Planning Team. Lily graduated with a BSc (Business Management) with Singapore Institute of Management.
Founded in 2011, Jana Care is a medical technology company that develops point-of-care diagnostics and digital coaching programs for the screening and management chronic diseases. Its novel CE marked diagnostic platform, Aina, enables testing of HbA1c, Blood Glucose, Lipid Profile and Hemoglobin using fingerstick blood samples, with new tests for NT-proBNP and Serum Creatinine in development. The company has also developed the Habits Program, a digital coaching program for patients with Diabetes and Congestive Heart Failure, in collaboration with leading academic medical centers globally.
Jana Care is headquartered in Boston, USA, and has established an ISO 13485 certified production facility in Bangalore, India.
Co-Founder, CEO
Sidhant worked at Medtronic in various R&D roles, before founding Jana Care. He received his BS and MS in Electrical Engineering from Georgia Tech and an MBA from Harvard Business School.
Co-Founder, CTO
Michal was a researcher at MIT working on computer vision and medical imaging, before starting Jana Care. He received his BS in Electrical Engineering from McGill University and MS in Computer Science from MIT.
Medfin is a healthcare start-up that is not only disrupting but also reimagining the surgeries landscape in India. Our aim is to give patients access to the latest surgical procedures that ensure quicker recovery and better outcomes at the most affordable costs.
Medfin’s model of healthcare delivery is designed to tailor the hospital care model for inclusion. People in developing countries like India often get side-lined owing to the lack of affordable care outside of government setups. Modularizing and re-arrangement of surgery blocks leads to never-before-seen flexibility and reduction in costs of surgeries.
Adding to this lowering of costs, Medfin actively works towards improving medical outcomes. Medfin works with surgeons who are trained in the latest minimally invasive day care procedures. These procedures ensure a hassle-free surgical experience and quick recovery for patients.
Medfin hand holds a patient right from the day of their first consultation, till they are discharged after surgery. Medfin handles all things in between including insurance processing, medical financing (EMI), booking of diagnostics and booking of follow-up consultations. Medfin is truly a discovery-to-recovery partner.
Founder & CEO
Arjun has over over 15+ years of experience in consumer internet companies in roles ranging from product manger to founder.He founded Bookadda.com and Housejoy prior to Medfin. Across the previous companies has raised ~$30mn. Arjun holds a Masters in Telecommunications from Ohio University.
Marketing Director
Arun Kumar has built his career with a focus on understanding customers and customer acquisition. He has been an integral part of setting up and scaling companies like TutorVista and Portea Medical. Arun has also co-founded two companies – MagicLane and Juno Clinic. Arun holds an MBA from XLRI, Jamshedpur.
Operations Director
Sidharth is the person to call when a company wants to undertake complex assignments, meet tight deadlines and deliver superior performance. He operates with a strong sense of urgency and dedication and thrive in fast pace setting. As part of the founding team of Housejoy, Sidharth has set up and scaled verticals such as home repairs and laundry among others. He holds an MBA from Babsons College, Boston.
Praktice.ai provides medical AI assistant for hospitals to help them engage their patients better and enhance clinical care. The company’s Artificial Intelligence software engages patients through voice or web by understanding their medical context via medical natural language processing, contextual understanding, speech recognition, triaging, guiding through the hospital operational processes and insurance-based care navigation to the right care provider within the hospital system.
This gives healthcare organizations a suite of AI applications to manage the patient intake and care management process. Its AI SaaS platform on one hand improves patient experience and provides a modern, consistent experience while enabling healthcare organizations to optimize their staffing and boost profitability.
Praktice.ai has launched it’s AI solutions with 6 enterprise hospital groups within UAE, Singapore and India in just a few months of launch of their product and has ambitions to make 70% of hospital operations driven by AI to make healthcare more personalised, patient centric and hence drive profitability for hospitals.
Co-Founder, COO
Dr. Akhila is an Oral Surgeon. Having experience in clinical practice with patients at healthcare organizations like Manipal and Vasan in Bangalore and having managed the Hospital Operations, she drives her passion in solving these complex hospital operations using technology.
Co-Founder, CEO
Srinath, having worked at Flipkart and 24x7 Inc previously, drives his passion of solving problems at scale. He Architected & managed the big data & insights system at Flipkart Supply Chain and an experience in speech technology for United Airlines at 24x7. He drives the Technology and the complex data architectures for the deeptech AI product of Praktice.ai
StanPlus is India’s largest medical emergency response platform that is working 24/7 to solve the emergency response with the use of technology and trained personnel. StanPlus is backed by a multi-city fleet of 3000+ ambulances with top-of-the-line equipment for both critical and non-critical care. StanPlus envisions solving the classic 3As of Indian healthcare – that is, awareness, affordability and access.
StanPlus has already partnered with 50+ hospitals in Hyderabad, Bengaluru, Mumbai, Coimbatore, and Kochi to manage their medical response systems also looking for expansion in order to serve patient transportation needs across and densely in the country.
CEO & Director
Prabhdeep has 10 years of experience in healthcare, with deep understanding across pharmaceuticals, hospitals and enterprise wellness. At Glenmark Pharmaceuticals, he was the EA to the Chairman, did corporate strategy, M&A, sales and product management, as well as led the P&L for a large emergency cardiac division.
Prabhdeep holds a pharmacist degree from NMIMS, and is an INSEAD MBA alumni.
THB offers clinical data and intelligence platforms for the healthcare ecosystem.
THB has developed some of the largest clinical platforms in S. Asia – e.g. vector borne diseases surveillance and trigger alerts across 15+ cities, diabetes population health and degree of control across ~25 cities, antibiotic stewardship platform across 100+ antibiotics. THB’s AI-enabled Patient Recommendation Engine for healthcare providers delivers enhanced patient care and compliance, and clinical outcomes.
THB is headquartered in Gurgaon, with presence in 6 satellite locations in India, and in Dubai, UAE. THB currrently oeprates in 5 countries across S. Asia and GCC.
CEO
Akansh has over 10 years of experience in management consulting and private equity across India, London, Dubai and US. Akansh has worked at Bain & Co, Abraaj Capital, Helion Ventures, Ennismore Capital. Akansh did his undergrad in computer science from IIIT Hyderabad, and MBA from London Business School.
CDO
Rohit has over 8 years of experience in big data analytics across American Express and FICO. Rohit is a hardcore numbers guy, and did his under-grad from IIT Kharagpur, and MBA from IIM Lucknow.
CTO
Rajesh has over 10 years of experience across Nvidia and Microsoft in India and US. Rajesh did his undergrad in computer science from IIIT Hyderabad, and masters from BITS Pilani.